Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 23, 2025Journal of Viral HepatitisOpen Access

Distinguishing True Immune Tolerant Hepatitis B Patients: Insights From Long‐Term Clinical Outcomes

View Full Paper
Ask AI
Bookmark
Share

Authors

JKJung Hyun KwonSLSung Won LeeHKHee Yeon Kim

Discussion

Loading...

Member takes

Overview

Retrospective analysis reveals chronic hepatitis B patients with criteria show minimal risk of HCC and may not need antiviral therapy.

Key Points

  • True immune tolerant hepatitis B patients exhibit minimal risk of severe liver events, significantly lower 10-year HCC rates than other groups.
  • Among 1064 chronic hepatitis B patients, those meeting strict criteria had no HCC cases and lower progression likelihood to immune-active status.
  • Analysis of clinical outcomes from a retrospective cohort corroborated key demographic factors such as younger age and female gender in lower risk profiles.
  • This research underscores the need for precise classification of immune tolerant patients to avoid unnecessary antiviral therapy.

Cite This Study

Kwon et al. (2025) studied this question.

synapsesocial.com/papers/68f9d6583f378872224924b3https://doi.org/10.1111/jvh.70083
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Indeterminate Phase/Grey Zone of Chronic Hepatitis B: Clinical Features, Outcomes and Molecular Insights2026
  2. 2IDDF2024-ABS-0177 Natural history and prognosis of chronic hepatitis B patients in the indeterminate phase2024
  3. 3Hepatocellular Carcinoma Risk Between Untreated Immune Tolerant Vs. Treated Immune Active Chronic Hepatitis B Patients2026
  4. 4Histopathological Evaluation and Treatment Necessity in Patients with Immune-Tolerant, Inactive, and Gray-Zone Chronic Hepatitis B2026
  5. 5Latest insights into the epidemiology, characteristics, and therapeutic strategies of chronic hepatitis B patients in indeterminate phase2024 · 7 citations